PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010
PF-00610355 – an inhaled β2 adrenoceptor agonist with superior potency and duration of action (DoA) to salmeterol in the conscious dog model of bronchoconstriction Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Synergistic bronchoprotective activity of the long-acting beta 2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011
Tracheal responsiveness to isoprenaline and beta2 -adrenoreceptor blockade by propranolol in cigarette smoke exposed and sensitized guinea pigs Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Effects of intravenous injection of TNF-a on the respiratory system of anesthetized rats Source: International Congress 2017 – Respiratory and exercise physiology Year: 2017
A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Increased tracheal responsiveness to β-adrenergic agonist and antagonist in ovalbumin sensitized guinea-pigs Source: Eur Respir J 2004; 24: Suppl. 48, 588s Year: 2004
Alpha-1L, but not alpha-1H, adrenoceptor antagonist prevents allergic bronchoconstriction in guinea pigs in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 104s Year: 2001
Leukotriene receptor antagonist versus corticotherapy on airways responsiveness in ovalbumin sensitized rats Source: Eur Respir J 2003; 22: Suppl. 45, 478s Year: 2003
Development of bronchospasm in normal and sensitized rabbits: exogenous administration vs. endogenous liberation of constrictor agonists Source: Eur Respir J 2005; 26: Suppl. 49, 365s Year: 2005
Safety and toleration of pf-00610355, a novel inhaled long acting β2 adrenoreceptor agonist Source: Annual Congress 2009 - New bronchodilators Year: 2009
Effects of tachykinin receptor antagonists on lung function and plasma extravasation induced by HCl intraoesophageal instillation in rabbits Source: Eur Respir J 2001; 18: Suppl. 33, 257s Year: 2001
Effect of an inhaled adenosine A2A agonist on the allergen induced late asthmatic response Source: Eur Respir J 2003; 22: Suppl. 45, 204s Year: 2003
The influence of epithelium on the responsiveness of guinea-pigs trachea to β-adrenergic agonist and antagonist Source: Eur Respir J 2002; 20: Suppl. 38, 504s Year: 2002
Effects of intracarotid arterial N-methyl-D-aspartate (NMDA) challenge on respiration and blood pressure in anaesthetized rats Source: Eur Respir J 2001; 18: Suppl. 33, 85s Year: 2001
Pharmacokinetics of PF-00610355, a novel inhaled long-acting β2 -adrenoreceptor agonist Source: Annual Congress 2009 - Next generation bronchodilators Year: 2009
Compound X – an inhaled β2 agonist with equivalent potency and superior duration of action (DOA)/ therapeutic index (TI) to salmeterol in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2008 - Novel treatments for respiratory disease Year: 2008
Comparison of response to lipopolysaccharide administered by intravenous, orotracheal and inhaled routes in rats Source: Eur Respir J 2007; 30: Suppl. 51, 135s Year: 2007
Influence of the long-acting beta 2-agonist indacaterol on the citric acid-induced cough model in conscious guinea pigs Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010
The cannabinoid receptor agonist, WIN 55,212-2, inhibits antigen-induced plasma extravasation in guinea pig airways Source: Annual Congress 2010 - Models of airways disease Year: 2010